Warby Parker Inc.
Warby Parker (NYSE: WRBY) designs and sells eyewear and provides vision care through an integrated online and retail business. Its products include prescription glasses and sunglasses, customizable lenses, lens replacements, and contact lenses from brands such as Acuvue, Biofinity, DAILIES, and Precision1; services… From the company’s description.
Over the twelve months to Sep 30, 2026, Warby Parker Inc. reported revenue of $934.66M, up 9.9% from a year earlier, and net income of $7.47M. Its operating margin was 0.2%, and operations generated $102.11M in cash. In fiscal 2025, it reported revenue of $871.90M, up 13.0% from fiscal 2024, and net income of $1.64M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Warby Parker Inc. does
In the company’s own words
Warby Parker (NYSE: WRBY) designs and sells eyewear and provides vision care through an integrated online and retail business. Its products include prescription glasses and sunglasses, customizable lenses, lens replacements, and contact lenses from brands such as Acuvue, Biofinity, DAILIES, and Precision1; services include in-store eye exams and a telehealth app for eligible customers renewing prescriptions. The company designs its eyewear in-house and sells through digital channels and retail stores, serving customers seeking vision correction, eye care, and related products. As of December 31, 2025, it operated 323 stores in the United States and Canada, and had 4,036 employees. Its product range also includes progressives and lens enhancements, while partnerships announced with Google and Samsung support development of AI-powered intelligent eyewear. Warby Parker’s Buy a Pair, Give a Pair program distributes a pair of glasses for each pair sold; more than 20 million pairs have been distributed in the United States and over 80 countries. Its website is www.warbyparker.com.
Company details
- Sector
- Consumer Discretionary
- Industry (SIC)
- Medical Instruments
- Headquarters
- NEW YORK, NY
- Fiscal year end
- December
- CIK
- 1504776
- SIC
- 3851
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Warby Parker Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Warby Parker Inc. · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Warby Parker Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Warby Parker Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Warby Parker Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Warby Parker Inc.'s last four quarterly filings that the numbers alone won't show?”